Market Currents

• Wednesday, September 24, 2008

• 09:11 AM Roche Holding (RHHBY.PK), in the middle of an expensive bid for Genentech (DNA), is in preliminary talks to invest in or takeover Israeli microRNA-based diagnostics and therapeutics developer Rosetta Genomics (ROSG). Comment!